Comparison of placebo and best available therapy for the treatment of myelofibrosis in the phase 3 COMFORT studies [PDF]
DiPersio, John F, et al,
core +1 more source
NETosis and Neutrophil Activity Quantification in Pediatric Patients with Essential Thrombocythemia. [PDF]
Adamanskaya EA +10 more
europepmc +1 more source
Long-term treatment with ruxolitinib for patients with myelofibrosis: 5-year update from the randomized, double-blind, placebo-controlled, phase 3 COMFORT-I trial [PDF]
DiPersio, John F, et al,
core +1 more source
Essential thrombocythemia as an initial presentation of polyneuropathy, organomegaly, endocrinopathy, M-protein, skin changes syndrome with complete response to the bortezomib, cyclophosphamide, dexamethasone regimen: a case report. [PDF]
Zangooie A +5 more
europepmc +1 more source
Abnormal Eosinophils With Large, Distinctly Basophilic Granules (Harlequin Cells) on Peripheral Blood Smear: A Clue for Diagnosing Chronic Myeloid Leukemia. [PDF]
Cai J, Yue C, Tomassetti S.
europepmc +1 more source
Coexistence of Essential Thrombocythemia and Waldenström Macroglobulinemia: A Case Report. [PDF]
Wallace M +4 more
europepmc +1 more source
Triple A Plus (AAA <sup>+</sup>) Survival Prediction Model for Essential Thrombocythemia: Analysis Involving 7308 Patients. [PDF]
Tefferi A +21 more
europepmc +1 more source
Prevalence of Chronic Obstructive Pulmonary Disease and Asthma in Polycythemia Vera and Essential Thrombocythemia and Its Prognostic Implications. [PDF]
Krecak I +11 more
europepmc +1 more source
Hemostasis via an endoscopic full-thickness suturing device with extended cap length method and red dichromatic imaging for deep colonic diverticular bleeding. [PDF]
Muramatsu T +6 more
europepmc +1 more source
Maladaptive somatic gene rescue as predisposition to JAK2 molecular abnormalities? Insights from an Israeli family. [PDF]
Borsani O, Gurnari C, Pietra D, Rumi E.
europepmc +1 more source

